Notícias Eulerpool Larimar Therapeutics

Larimar Therapeutics Notícias de ações

Larimar Therapeutics é observado por muitos jornalistas e investidores em todo o mundo. As notícias mais recentes de Larimar Therapeutics nós reunimos aqui.

• 8 de julho ·

  Yahoo
  Larimar Therapeutics Publishes Nonclinical Data Supporting the Therapeutic Potential of Nomlabofusp in Patients with Friedreich’s Ataxia
• 23 de junho ·

  Yahoo
  Larimar Therapeutics Announces FDA Recommendations on Safety Database, and Other Details of Nomlabofusp BLA Submission for Friedreich’s Ataxia Program
• 21 de maio ·

  Yahoo
  Larimar Therapeutics, Inc.’s (LRMR): Analysts See 957% Upside Potential
• 30 de abril ·

  Yahoo
  Larimar Therapeutics Reports First Quarter 2025 Financial Results
• 4 de abril ·

  SeekingAlpha
  Larimar Therapeutics: Initiating Hold Rating With Upcoming Catalysts
• 28 de março ·

  Yahoo
  Is Larimar Therapeutics (NASDAQ:LRMR) In A Good Position To Invest In Growth?
• 2 de março ·

  SeekingAlpha
  Invest In A New Biotech Bull Market With XBI And IBB
• 21 de janeiro ·

  SeekingAlpha
  Solid Biosciences: Differentiating Factors Of SGT-212 To Set Itself Apart
• 6 de janeiro ·

  Yahoo
  Bullish Larimar Therapeutics Insiders Loaded Up On US$522.0k Of Stock
• 3 de janeiro ·

  SeekingAlpha
  Larimar Therapeutics: Positive Friedreich's Ataxia Data Can Only Get Better